Low dosage kinetic hydrate inhibitors (KHIs) are a kind of alternative chemical additives to prevent gas hydrate formation in oil & gas production wells and transportation pipelines. In this work, a series of KHIs were experimentally synthesized with N-vinyl caprolactam (N-VCap) and vinyl ether including vinyl ether, vinyl n-butyl ether, vinyl isobutyl ether, triethylene glycol divinyl ether, with the mole ratio ranging from 9:1 to 5:5. The inhibition performance of new-synthesized KHIs on the formation process of methane hydrate were examined and compared with that of commercial N-vinyl caprolactam PVCap. Several ethylenediamine reagents were used as synergists and tested to improve the inhibition capacity of new-synthesized KHIs. The experimental results demonstrate that the introduction of ether groups on PVCap improves the performance of hydrate inhibitors. PVCap-VNBE (N-VCap: vinyl n-butyl ether = 5:5) showed the best inhibition performance for methane hydrate, which could extend the TVO to 1251 min under 6 K subcooling. N,N'-dimethylethylenediamine shows the best synergistic effect for PVCap-VNBE (5:5), and extends the TVO by 2.75 times at 7 K subcooling. Additionally, the relationship between hydrate inhibition performance and interfacial tension of newly-synthesized KHIs under high pressure were studied. It shows that the lower interfacial tension of KHIs would result in longer onset time, exhibiting better inhibition performance.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: